Skip to content

NRTI-sparing combination of ritonavir-boosted indinavir and efavirenz improves fat loss but worsens blood fat and sugar levels

Staccato study suggests that some CD4-guided treatment interruptions can be safe

Persistence of infection with HPV linked to the individual's, and the virus's region of origin

Severity of NRTI-mediated mitochondrial toxicity differs in blood and fat cells

HIV-positive women often infected with multiple high-risk HPV strains not covered by vaccine

People with history of depression more likely to stop efavirenz due to mental health problems

Cotrimoxazole prophylaxis is feasible and effective in HIV-1 infected adult Ugandans but resistance concerns persist

Neuropathy less likely in carriers of haemochromatosis gene

Oral and anogenital shedding of HSV-2 occurs more frequently in HIV-positive men, often without symptoms